100 mg • NSAID / Analgesic & Anti-inflammatory
Strength : 100 mg
Therapeutic Class : NSAID / Analgesic & Anti-inflammatory
Packing : 1 x 5 Suppositories
Export Status : Available
Diclofenac Sodium 100 mg is a non-steroidal anti-inflammatory drug (NSAID) formulated as a rectal suppository. Diclofenac is widely used for the symptomatic management of pain, inflammation and swelling associated with various musculoskeletal, rheumatic and inflammatory conditions.
Diclofenac Sodium Suppositories provide an alternative route of administration for patients when rectal administration is prescribed by a healthcare professional. This pharmaceutical formulation is intended for rectal use and should be administered according to the approved product information and medical advice.
Each suppository contains:
Active Ingredient: Diclofenac Sodium
Strength: 100 mg
Dosage Form: Rectal Suppository
Route of Administration: Rectal
Pharmaceutical Category: Non-Steroidal Anti-Inflammatory Drug (NSAID)
Packaging: 1 x 5 Suppositories
Diclofenac Sodium belongs to the non-steroidal anti-inflammatory drug (NSAID) class. It possesses analgesic, anti-inflammatory and antipyretic properties and is used in the symptomatic treatment of various painful and inflammatory conditions.
Diclofenac Sodium Suppositories may be prescribed for the management of pain and inflammation associated with:
Rheumatoid arthritis
Osteoarthritis
Ankylosing spondylitis
Acute gout
Lower back pain
Acute musculoskeletal disorders
Tendinitis
Tenosynovitis
Bursitis
Sprains and strains
Dislocations
Pain associated with certain injuries
Post-operative pain and inflammation in selected surgical procedures
Dental and other minor surgical pain, when medically indicated
The suitability of Diclofenac Sodium depends on the patient's medical condition, clinical assessment and the applicable prescribing information.
Diclofenac Sodium works by inhibiting cyclooxygenase (COX) enzymes involved in the synthesis of prostaglandins. Prostaglandins are substances in the body that contribute to pain, inflammation, swelling and fever.
By reducing prostaglandin synthesis, diclofenac helps relieve pain, reduce inflammation and improve symptoms associated with inflammatory disorders.
Diclofenac Sodium Suppositories are designed for rectal administration. Following insertion into the rectum, the suppository base melts or dissolves, allowing the active ingredient to be released and absorbed.
Rectal administration may be prescribed in situations where an alternative route of administration is considered appropriate. The suppository must not be swallowed and should only be used according to the prescribed instructions.
Diclofenac Sodium 100 mg Suppositories are intended for rectal use only.
The dosage and duration of treatment should be determined by a qualified healthcare professional according to the patient's condition, age, medical history, other medicines and the applicable prescribing information.
In some approved adult product information, a 100 mg suppository may be used as a once-daily treatment. The maximum daily dose of diclofenac from all dosage forms must be considered, and different formulations should not be combined without medical advice.
General administration instructions:
Wash hands before and after administration.
Remove the suppository from its protective packaging.
Follow the instructions provided by the healthcare professional or patient leaflet.
Insert the suppository gently into the rectum as directed.
Do not swallow the suppository.
This product is not intended for self-medication.
Like other NSAIDs, Diclofenac Sodium may cause adverse reactions. Side effects may vary according to the individual patient, dose, duration of treatment and underlying medical conditions.
Possible side effects include:
Nausea
Vomiting
Diarrhoea
Abdominal discomfort
Indigestion
Stomach pain
Headache
Dizziness
Loss of appetite
Increased liver enzyme levels
Diclofenac may cause gastrointestinal adverse reactions, including:
Gastritis
Heartburn
Abdominal pain
Gastrointestinal irritation
Stomach or intestinal ulcers
Gastrointestinal bleeding
Gastrointestinal perforation
Serious gastrointestinal complications may occur even in patients without a previous history of gastrointestinal disorders.
As this formulation is administered rectally, local adverse reactions may occur, including:
Rectal irritation
Burning sensation at the site of administration
Rectal discomfort
Irritation or worsening of haemorrhoids
Rectal bleeding
Inflammation of the rectal mucosa
Diclofenac may be associated with cardiovascular risks, particularly with higher doses and prolonged treatment.
Potential cardiovascular adverse reactions include:
Increased blood pressure
Fluid retention
Swelling of the ankles or legs
Palpitations
Heart failure
Increased risk of cardiovascular thrombotic events, including heart attack and stroke
Patients with cardiovascular disease or risk factors require careful medical assessment before treatment.
Diclofenac may affect kidney function, particularly in patients with pre-existing renal disease, dehydration, heart failure or other risk factors.
Possible renal complications include:
Reduced kidney function
Fluid retention
Changes in urine output
Blood or protein in the urine
Acute kidney injury in susceptible patients
Diclofenac may cause abnormalities in liver function and, in rare cases, serious hepatic injury.
Possible manifestations include:
Increased liver enzymes
Hepatitis
Jaundice
Liver dysfunction
Rare cases of severe liver injury
Possible hypersensitivity reactions include:
Skin rash
Itching
Urticaria
Swelling of the face or lips
Bronchospasm
Severe allergic reactions
Rare severe skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis
Patients should seek urgent medical attention if they experience:
Chest pain
Difficulty breathing
Sudden weakness on one side of the body
Sudden difficulty speaking
Severe allergic reaction
Swelling of the face or throat
Vomiting blood
Black or tarry stools
Severe abdominal pain
Yellowing of the skin or eyes
Severe or unusual skin reactions
Sudden reduction in urine output
Diclofenac should be discontinued and medical attention sought if serious adverse reactions are suspected.
Diclofenac Sodium may be contraindicated in patients with:
Hypersensitivity to diclofenac or any ingredient of the formulation
Previous allergic reactions to aspirin or other NSAIDs
Active peptic ulcer disease
Active gastrointestinal bleeding
Previous gastrointestinal perforation or bleeding associated with NSAID treatment
Severe heart failure
Severe renal impairment
Severe hepatic impairment
Established cardiovascular or cerebrovascular disease, depending on the approved product information
Active rectal bleeding
Proctitis or certain other rectal disorders
Third trimester of pregnancy
The contraindications must be checked against the approved prescribing information applicable to the destination country.
Diclofenac Sodium should be used with caution in patients with:
A history of gastrointestinal ulcers or bleeding
Crohn's disease or ulcerative colitis
Hypertension
Cardiovascular disease
Diabetes
Hyperlipidaemia
Kidney disorders
Liver disorders
Asthma
Allergic conditions
Bleeding disorders
Dehydration
Advanced age
Low body weight
NSAIDs may mask certain signs of infection, including fever and pain. Patients undergoing treatment should be assessed if symptoms persist or worsen.
The lowest effective dose for the shortest necessary duration should be considered according to the prescribing information and healthcare professional's advice.
Diclofenac use during pregnancy requires medical assessment.
NSAIDs may pose risks to the fetus, particularly during later pregnancy. Diclofenac should not be used during the third trimester of pregnancy. Use during earlier stages of pregnancy should only be considered when medically justified and under healthcare professional supervision.
Pregnant patients should not use this medicine without consulting a healthcare professional.
Diclofenac use during breastfeeding should be assessed by a healthcare professional. Depending on the approved product information and the clinical situation, use may be discouraged or require precautions.
Diclofenac may interact with other medicines. Potential interactions include:
Anticoagulants, such as warfarin
Antiplatelet medicines
Other NSAIDs
Aspirin
Corticosteroids
Selective serotonin reuptake inhibitors (SSRIs)
Diuretics
ACE inhibitors
Angiotensin II receptor blockers
Lithium
Methotrexate
Ciclosporin
Tacrolimus
Digoxin
Patients should inform their healthcare professional about all medicines, supplements and treatments they are currently taking.
Elderly patients may be more susceptible to gastrointestinal, cardiovascular and renal adverse reactions associated with NSAIDs.
Medical supervision is recommended, and treatment should follow the applicable prescribing information.
Diclofenac Sodium 100 mg Suppositories may not be suitable for paediatric patients. Paediatric use depends on the strength, formulation, approved indication and country-specific prescribing information.
The 100 mg strength should not be used in children unless specifically authorised by an applicable prescribing guideline, which is generally not the case for this strength.
Store Diclofenac Sodium Suppositories according to the storage instructions provided on the approved product packaging.
Protect the product from excessive heat, moisture and direct sunlight. Keep out of reach of children. Do not use after the expiry date.
Specific storage temperatures and conditions should be confirmed against the approved product specifications.
Diclofenac Sodium 100 mg Suppositories are available in packaging configurations subject to manufacturing and market requirements.
Product Strength: 100 mg
Pack Configuration: 1 x 5 Suppositories
Dosage Form: Rectal Suppository
Packaging: Subject to market and procurement requirements
Packaging, artwork, labelling and commercial supply requirements may be discussed with pharmaceutical buyers and importers.
Global Entra Pharma provides pharmaceutical product sourcing and export-oriented supply coordination for international pharmaceutical buyers, importers, distributors, wholesalers and institutional procurement organisations.
Diclofenac Sodium 100 mg is listed for pharmaceutical sourcing inquiries and international buyer requirements. Product availability, documentation, packaging specifications, commercial quantities and supply arrangements are subject to confirmation.
We support pharmaceutical buyers across African and international markets, including markets in Africa, Asia, the Middle East, Latin America and other regions, subject to applicable local import regulations, registration requirements and market authorisations.
Buyers and distributors interested in Diclofenac Sodium 100 mg may contact Global Entra Pharma for product information, commercial inquiries and pharmaceutical supply coordination.
This product information is provided for general pharmaceutical product reference and business information purposes only. It is not intended to replace medical advice, diagnosis or treatment. The use of Diclofenac Sodium should be based on the approved product information, prescription requirements and guidance of a qualified healthcare professional. Product indications, contraindications, warnings and regulatory status may differ between countries.
| Product Name | Diclofenac Sodium |
|---|---|
| Dosage Form | Suppository |
| Strength | 100 mg |
| Therapeutic Category | NSAID / Analgesic & Anti-inflammatory |
| Packing | 1 x 5 Suppositories |
| Export Status | Available |